Highlighting AMRIT’s achievements, Shri Nadda noted that providing 50% discounts on branded medicines has directly benefited ...

Research has revealed the shocking lack of access to essential medicines in India, despite thousands being approved in an attempt to generate wider availability. Research has revealed the shocking ...

India's National Pharmaceutical Pricing Authority (NPPA) is busy on both the pharma and device fronts to bring down costs to consumers. But the efforts may do more harm than good, according to an ...

India’s drug regulator is proposing to weaken drug oversight. Yet the Indian drug industry is reeling from production problems in dozens of plants, and a loosening of the rules is a danger for ...

New Delhi, India's evolving regulatory framework and evidence-based policy initiatives in traditional medicine were showcased at a major international conclave of global authorities and experts being ...